Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Norethindrone - Generic Drug Details

« Back to Dashboard
Norethindrone is the generic ingredient in twelve branded drugs marketed by Aurobindo Pharma Ltd, Glenmark Generics, Novast Labs Ltd, Lupin Ltd, Mayne Pharma, Janssen Pharms, Apil, Amneal Pharms, Novast Labs, Jai Pharma Ltd, Parke Davis, Duramed Res, and Barr, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for norethindrone. Nineteen suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: norethindrone

Drug Master File Entries: see list26
Suppliers / Packaging: see list19
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: norethindrone

Ingredient-typeProgesterone Congeners
Drug ClassProgestin

Tentative approvals for NORETHINDRONE

Applicant Application No. Form Dosage
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs
TABLET;ORAL-28200961-001Sep 13, 2013RXNo► subscribe► subscribe
Jai Pharma Ltd
TABLET;ORAL-28200980-001Jun 12, 2013RXNo► subscribe► subscribe
Janssen Pharms
TABLET;ORAL-28016954-001Approved Prior to Jan 1, 1982RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.